A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy
Clinical trial NCT07029139 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07029139
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2027-04-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.